Members |
targetComponentId |
Verruca plana |
Plane wart |
Verruca vulgaris |
Verruca vulgaris |
dermatos orsakad av ryggradsdjur |
Animal-induced dermatosis |
Vesicular stomatitis |
Vesicular stomatitis |
vesikulär stomatit-virus, Cocal |
Cocal virus (organism) |
Vespa |
Vespa |
Vestibular neuronitis |
Epidemic vertigo |
Veterinary nursing AND/OR grooming procedure |
Nursing procedure |
vibration av livmoderhalsen |
Uterine cervix manipulation |
Vibration of cervix |
Uterine cervix manipulation |
Vibrio anguillarium |
Listonella anguillarum (organism) |
Vibrio carchariae |
Vibrio harveyi |
Vibrio costicola |
Salinivibrio costicola |
Vibrio damsela |
Photobacterium damselae (organism) |
Vibrio fischeri |
Aliivibrio fischeri |
Vibrio hollisae |
Grimontia hollisae (organism) |
Vibrio marinus |
Moritella marina (organism) |
Vibrio trachuri |
Vibrio harveyi |
Vibrionaceae ichthyoenteri |
Vibrio ichthyoenteri (organism) |
trakasserar andra |
Abusive behavior towards people (finding) |
Villous adenoma |
Villous adenoma (morphologic abnormality) |
vinblastinsulfat 30 mg/30 ml, injektionsvätska, lösning |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
vinblastinsulfat 30 mg/30ml, för infusion |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
vinblastinsulfat 50 mg/50 ml, infusionsvätska, lösning |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
vinblastinsulfat 50 mg/50 ml, för infusion |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
Vinca alkaloid |
Vinca alkaloid |
vinkristin 1 mg, pulver och vätska till injektionslösning, flaska |
Vincristine only product in parenteral dose form |
vinkristin 1 mg, pulver till injektionsvätska, lösning, flaska |
Vincristine only product in parenteral dose form |
vinkristin 2 mg, pulver och vätska till injektionslösning, flaska |
Vincristine only product in parenteral dose form |
vinkristin 2 mg, pulver till injektionsvätska, lösning, flaska |
Vincristine only product in parenteral dose form |
vinkristin 5 mg, pulver och vätska till injektionslösning, flaska |
Vincristine only product in parenteral dose form |
vinkristin 5 mg, pulver till injektionsvätska, lösning, flaska |
Vincristine only product in parenteral dose form |
vinkristinsulfat 10 mg/50 ml, infusionsvätska, lösning |
Vincristine only product in parenteral dose form |
vinkristinsulfat 10 mg/50 ml, för infusion |
Vincristine only product in parenteral dose form |
vinkristinsulfat 5 mg/50 ml, infusionsvätska, lösning |
Vincristine only product in parenteral dose form |
vinkristinsulfat 5 mg/50 ml, för infusion |
Vincristine only product in parenteral dose form |
vinorelbin 10 mg/1 ml, intravenös vätska, lösning |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
vinorelbin 50 mg/5 ml, intravenös vätska, lösning |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Vinorelbine tartrate 10mg/mL injection solution 1mL vial |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Vinorelbine tartrate 10mg/mL injection solution 5mL vial |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Vinorelbine tartrate 10mg/mL solution |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Viper type C oncovirus |
Viper retrovirus (organism) |
Vipera |
Subfamily Viperinae (organism) |
Vipera persica |
Pseudocerastes persicus |
Viral gastroenteritis due to other viral agents |
Viral gastroenteritis |
Viral hepatitis, non-A, non-B |
Viral hepatitis C |
virusinfektion, indelning efter lokalisation |
Viral disease |
Visually threatening diabetic retinopathy |
Visually threatening diabetic retinopathy |
Vitamin A deficiency with other ocular manifestations |
Vitamin A deficiency with ocular manifestation |
allergi mot B12-vitamin |
Allergy to vitamin B12 and/or vitamin B12 derivative (finding) |
Vitamin B>12< deficiency neuropathy |
Subacute combined degeneration of spinal cord |
D3-vitaminmetabolit |
Vitamin D analogue |
Vitamin P preparation |
Bioflavonoid |
Vitropression |
Diascopy procedure |
Vocal |
Vocal resonance |
röststörning orsakad av transsexualism |
Speech and language disorder |
beroende av flyktigt inhalationsmedel med nuvarande användning |
Inhalant dependence |
volymstyrd ventilation |
Continuous mandatory ventilation (regime/therapy) |
Vomiting |
Vomiting (disorder) |
kräkning förenat med andra psykiska störningar |
Psychogenic vomiting |
Vomiting disorder |
Vomiting (disorder) |
fynd som rör TNM-stadieindelning av tumör i vulva |
American Joint Committee on Cancer allowable value |
Vulva excision |
Vulvectomy |
Vulvar ulceration |
Ulceration of vulva |
W plasty NEC |
W-plasty of skin |
Waardenburg syndrome, types I and II |
Waardenburg syndrome |
Wagstaffes fraktur |
Avulsion fracture of anterior fibula (disorder) |
warfarin 2 mg/ml, pulver till injektionsvätska, lösning |
Warfarin sodium 5 mg powder for solution for injection vial |
varm miljö |
Warm environment |
Wart snake |
Family Acrochordidae (organism) |
Washing |
Action |
Washing of animal |
Bathing patient |
vatten till injektion, påse 100 ml |
Water only product in parenteral dose form |
vatten till injektion, ampull 10 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
vatten till injektion, påse 1000 ml |
Water only product in parenteral dose form |
vatten till injektion, ampull 1 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
vatten till injektion, ampull 20 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
vatten till injektion, ampull 2 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
vatten till injektion, ampull 50 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
vatten till injektion, ampull 5 ml |
Product containing precisely water 1 gram/1 milliliter conventional release solution for injection (clinical drug) |
Watkins-Wertheims operation av livmodern |
Surgical repair of prolapsed uterus |
Weakening of extraocular muscle |
Strabismus surgery |
påbörjad avvänjning från mekanisk andningshjälp |
Weaning from mechanically assisted ventilation commenced |
frakturtyper enligt Weber |
Fracture configurations |
frakturtyp A enligt Weber |
Weber type A fracture (morphologic abnormality) |
frakturtyp B enligt Weber |
Weber type B fracture |
frakturtyp C enligt Weber |
Weber type C fracture |
kilosteotomi, aktivitet |
Incision - action |
Weekly |
Weekly (qualifier value) |
Weeksella zoohelcum |
Bergeyella zoohelcum |
viktsymtom |
Weight finding |
Weight symptom |
Weight finding |
Weight symptom NOS |
Weight finding |
Weight symptom NOS |
Weight finding |
Weissenbacher-Zweymullers syndrom |
Stickler syndrome type 3 (disorder) |
rullstolsburen |
Able to mobilise using wheelchair |
vit färg |
White color (qualifier value) |
White spot lesions of teeth |
Incipient enamel caries |
kroppen, som helhet |
Entire body as a whole |
bröst som helhet |
Entire breast |
framfot, som helhet |
Entire forefoot region of foot (body structure) |